Cargando…
Human fibulin-3 protein variant expresses anti-cancer effects in the malignant glioma extracellular compartment in intracranial xenograft models
BACKGROUND: Decades of cytotoxic and more recently immunotherapy treatments for malignant glioma have had limited success due to dynamic intra-tumoral heterogeneity. The dynamic interplay of cancer cell subpopulations has been found to be under the control of proteins in the cancer microenvironment....
Autores principales: | Li, Yanyan, Hu, Yuan, Liu, Chuanjin, Wang, Qingyue, Han, Xiaoxiao, Han, Yong, Xie, Xue-Shun, Chen, Xiong-Hui, Li, Xiang, Siegel, Eric R., Afrasiabi, Kambiz, Linskey, Mark E., Zhou, You-Xin, Zhou, Yi-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739735/ https://www.ncbi.nlm.nih.gov/pubmed/29290950 http://dx.doi.org/10.18632/oncotarget.22344 |
Ejemplares similares
-
Dual antivascular function of human fibulin‐3 variant, a potential new drug discovery strategy for glioblastoma
por: Ke, Chao, et al.
Publicado: (2020) -
Weaponizing human EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1) for 21(st) century cancer therapeutics
por: Zhou, Yi-Hong, et al.
Publicado: (2016) -
Exploiting Cancer’s Tactics to Make Cancer a Manageable Chronic Disease
por: Afrasiabi, Kambiz, et al.
Publicado: (2020) -
EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment
por: Hu, Yuanjie, et al.
Publicado: (2011) -
Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure
Publicado: (1990)